Flagship Harbor Advisors LLC lowered its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 1.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,909 shares of the company’s stock after selling 90 shares during the period. Flagship Harbor Advisors LLC’s holdings in Express Scripts Holding were worth $391,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Hancock Holding Co. increased its position in Express Scripts Holding by 9.9% in the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock worth $12,094,000 after buying an additional 16,536 shares in the last quarter. Van ECK Associates Corp increased its position in Express Scripts Holding by 28.8% in the first quarter. Van ECK Associates Corp now owns 373,636 shares of the company’s stock worth $24,626,000 after buying an additional 83,568 shares in the last quarter. Twin Capital Management Inc. increased its position in Express Scripts Holding by 0.8% in the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock worth $3,069,000 after buying an additional 360 shares in the last quarter. Wilkins Investment Counsel Inc. increased its position in Express Scripts Holding by 6.9% in the first quarter. Wilkins Investment Counsel Inc. now owns 118,336 shares of the company’s stock worth $7,800,000 after buying an additional 7,630 shares in the last quarter. Finally, ACR Alpine Capital Research LLC increased its position in Express Scripts Holding by 6.3% in the first quarter. ACR Alpine Capital Research LLC now owns 1,463,799 shares of the company’s stock worth $96,479,000 after buying an additional 87,292 shares in the last quarter. 90.20% of the stock is owned by institutional investors.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded down 1.14% during trading on Thursday, reaching $60.50. The company had a trading volume of 1,198,549 shares. The stock has a 50 day moving average price of $62.96 and a 200 day moving average price of $64.58. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $77.61. The firm has a market capitalization of $34.94 billion, a PE ratio of 10.50 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same quarter last year, the firm earned $1.57 EPS. Express Scripts Holding’s revenue for the quarter was up .5% compared to the same quarter last year. On average, equities research analysts forecast that Express Scripts Holding Company will post $6.99 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was first published by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/10/express-scripts-holding-company-nasdaqesrx-shares-sold-by-flagship-harbor-advisors-llc.html.

ESRX has been the subject of a number of research analyst reports. ValuEngine downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Mizuho lowered their price objective on shares of Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating for the company in a research report on Tuesday, April 25th. Needham & Company LLC assumed coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating for the company. Cowen and Company reaffirmed an “outperform” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a research report on Friday, June 9th. Finally, Evercore ISI lowered their price objective on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research report on Wednesday, April 26th. Four equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $70.81.

In related news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total value of $66,088.00. Following the sale, the vice president now owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.68% of the stock is owned by insiders.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.